POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HIGHER-RISK MYELODYSPLASTIC SYNDROME

被引：0
|
作者：
Choi, E. -J. [1 ]
Park, H. -S. [1 ]
Lee, J. -H. [1 ]
Lee, K. -H. [1 ]
Lee, J. -H. [1 ]
机构：
[1] Univ Ulsan, Dept Hematol, Asan Med Ctr, Coll Med, Seoul, South Korea
来源：
LEUKEMIA RESEARCH | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P58
引用
下载
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [21] A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis
    Morozova, Elena Vladislavovna
    Barabanshikova, Maria Vladimirovna
    Moiseev, Ivan Sergeevich
    Shakirova, Alena Igorevna
    Barhatov, Ildar Munerovich
    Ushal, Inna Edvardovna
    Rodionov, Gennadij Georgievich
    Moiseev, Sergey Ivanovich
    Surkova, Elena Arkadjevna
    Lapin, Sergey Vladimirovich
    Vlasova, Julia Jurjevna
    Rudakova, Tatjana Alexandrovna
    Darskaya, Elena Igorevna
    Baykov, Vadim Valentinovich
    Alyanski, Alksandr Leonidovich
    Bondarenko, Sergey Nikolaevich
    Afanasyev, Boris Vladimirovich
    ACTA HAEMATOLOGICA, 2021, 144 (02) : 158 - 165
  • [22] Post-Transplant Cyclophosphamide Combined with Anti-Thymocyte Globulin as Graft-versus-Host Disease Prophylaxis for Allogeneic Hematopoietic Cell Transplantation in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Alanazi, Wael
    Chen, Shiyi
    Lipton, Jeffrey H.
    Kim, Dennis D.
    Viswabandya, Auro
    Kumar, Rajat
    Lam, Wilson
    Law, Arjun D.
    Al-Shaibani, Zeyad
    Mattsson, Jonas
    Michelis, Fotios V.
    ACTA HAEMATOLOGICA, 2021, 144 (01) : 66 - 73
  • [23] Mechanisms of Graft-versus-Host Disease Prevention by Post-transplantation Cyclophosphamide: An Evolving Understanding
    Nunes, Natalia S.
    Kanakry, Christopher G.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [24] Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients
    El-Deen, Mustafa O. Sharaf
    Soliman, Moetaza M.
    Al-Azab, Gamal
    Samra, Mohamed
    Shams, Mohammad E. E.
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2024, 491
  • [25] Post-transplantation NK cell is a useful predictor of graft-versus-host-disease in allogeneic hematopoietic stem cell transplantation
    Kim, Seo Yeon
    Lee, Hyewon
    Shim, Hyoeun
    Eom, Hyeon-Seok
    Kong, Sun-Young
    CANCER RESEARCH, 2014, 74 (19)
  • [26] Graft Versus Host Disease Prophylaxis in Matched Donor Stem Cell Transplantation: Post-transplantation Cyclophosphamide Combinations Versus Methotrexate/Tacrolimus
    Ashouri, Karam
    Fernandez, Eduardo
    Ginosyan, Anush
    Feliciano, Carissa M.
    Hom, Brian
    Rodman, Jack
    Ali, Amir
    Ladha, Abdullah
    Woan, Karrune
    Tam, Eric
    Chaudhary, Preet
    Yaghmour, George
    TRANSPLANTATION PROCEEDINGS, 2024, 56 (07) : 1 - 7
  • [27] HLA-Matched Sibling Stem Cell Transplantation Using Post-Transplantation Cyclophosphamide as Graft-Versus-Host Disease Prophylaxis: A Single Center Experience
    Fathy, Gamal M.
    Mahmoud, Hossam K.
    El-Haddad, Alaa
    Fahmy, Omar
    Abdelfattah, Raafat
    Abdel-Mooti, Mohamed
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S262 - S262
  • [28] PROPHYLAXIS OF GRAFT VERSUS HOST DISEASE WITH CYCLOPHOSPHAMIDE IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION. EXPERIENCE OF A CENTER
    Lopez-Munoz, Nieves
    Sanchez, Pina Jose Maria
    Calbacho, Maria
    Vera, Guerrero Elena
    Hidalgo, Soto Marta
    Buendia, Urena Buenaven-Tura
    De Nicolas, Sol Rodrigo
    Gutierrez, Lopez de Ocariz Xabier
    Iniguez, Garcia Rodrigo
    Poza, Santaella Maria
    Zamanillo, Herreros Irene
    Martinez-Lopez, Joaquin
    HAEMATOLOGICA, 2020, 105 : 268 - 269
  • [29] Sirolimus Is an Acceptable Alternative to Tacrolimus for Graft-versus-Host Disease Prophylaxis after Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide
    Elmariah, Hany
    Otoukesh, Salman
    Kumar, Ambuj
    Ali, Haris
    Arslan, Shukaib
    Shouse, Geoffrey
    Pourhassan, Hoda
    Nishihori, Taiga
    Faramand, Rawan
    Mishra, Asmita
    Khimani, Farhad
    Fernandez, Hugo
    Lazaryan, Aleksandr
    Nieder, Michael
    Perez, Lia
    Liu, Hien
    Nakamura, Ryotaro
    Pidala, Joseph
    Marcucci, Guido
    Forman, Stephen J.
    Anasetti, Claudio
    Locke, Frederick
    Bejanyan, Nelli
    Malki, Monzr M. Al
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : e1 - e11
  • [30] Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis
    Oshrine, Benjamin
    Innamarato, Patrick
    Branthoover, Holly
    Nagle, Luz
    Verdugo, Patrick
    Pilon-Thomas, Shari
    Beatty, Matthew
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (04): : 203.e1 - 203.e7
12345